within Pharmacolibrary.Drugs.ATC.S;

model S01CA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.0,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Methylprednisolone and antiinfectives (ATC S01CA08) is a combination ocular drug preparation intended for the treatment of eye infections and inflammation. Methylprednisolone is a corticosteroid used for its anti-inflammatory and immunosuppressive properties, while the antiinfective component prevents or treats bacterial infections. This combination is primarily used in ophthalmology to manage inflammatory eye conditions with a concurrent risk or presence of infection. Not all countries have this specific combination approved, and its availability may vary.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic studies or published PK models specific to the combined preparation of methylprednisolone and antiinfectives (S01CA08) for ophthalmic use were identified in the literature. Thus, PK parameter values are not directly available.</p><h4>References</h4><ol><li><p>Suetsugu, K, et al., &amp; Ieiri, I (2021). Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study. <i>Drugs in R&amp;D</i> 21(4) 419–429. DOI:<a href=&quot;https://doi.org/10.1007/s40268-021-00365-0&quot;>10.1007/s40268-021-00365-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34655050/&quot;>https://pubmed.ncbi.nlm.nih.gov/34655050</a></p></li><li><p>Glynn, AM, et al., &amp; Jusko, WJ (1986). Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion. <i>Clinical pharmacology and therapeutics</i> 39(6) 654–659. DOI:<a href=&quot;https://doi.org/10.1038/clpt.1986.114&quot;>10.1038/clpt.1986.114</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3709030/&quot;>https://pubmed.ncbi.nlm.nih.gov/3709030</a></p></li><li><p>Lebrun-Vignes, B, et al., &amp; Warot, D (2001). Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. <i>British journal of clinical pharmacology</i> 51(5) 443–450. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2125.2001.01372.x&quot;>10.1046/j.1365-2125.2001.01372.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11422002/&quot;>https://pubmed.ncbi.nlm.nih.gov/11422002</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01CA08;
